Kemoradioterapi

Kemoradioterapi is a combined treatment approach that involves the use of chemotherapy and radiation therapy to treat cancer. This multimodal therapy is often used for locally advanced cancers, such as those in the head and neck region, where surgery alone may not be sufficient to achieve a cure. The primary goal of kemoradioterapi is to control the primary tumor and reduce the risk of recurrence by destroying cancer cells and shrinking the tumor size.

Chemotherapy in kemoradioterapi typically involves the administration of drugs that are delivered systemically, either intravenously or orally, to target rapidly dividing cancer cells throughout the body. Radiation therapy, on the other hand, delivers high-energy radiation directly to the tumor site to kill cancer cells and damage the tumor's blood supply. The combination of these two modalities aims to enhance the overall effectiveness of treatment by targeting cancer cells in different ways.

The timing and sequencing of chemotherapy and radiation therapy in kemoradioterapi can vary depending on the specific cancer type and the treatment plan. In some cases, chemotherapy may be given before radiation therapy to shrink the tumor size and make it more radiosensitive. In other cases, chemotherapy may be administered concurrently with radiation therapy to enhance the radiosensitivity of cancer cells. The duration of treatment can range from several weeks to several months, depending on the cancer type and the patient's response to therapy.

Kemoradioterapi is typically followed by adjuvant therapy, which may include additional chemotherapy, radiation therapy, or immunotherapy, to further reduce the risk of recurrence. The overall goal of kemoradioterapi is to improve survival rates and quality of life for cancer patients by providing a more comprehensive and effective treatment approach.